NASDAQ:CUTR - Cutera Stock Price, Forecast & News

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera, Inc. (NASDAQ:CUTR) released its quarterly earnings results on Thursday, November, 7th. The medical device company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.23. The medical device company had revenue of $46.12 million for the quarter, compared to the consensus estimate of $41.66 million. Cutera had a negative return on equity of 84.67% and a negative net margin of 20.84%. The firm's quarterly revenue was up 13.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.11 EPS. View Cutera's Earnings History.

Cutera is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Cutera.

Cutera updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180.9-181.9 million, compared to the consensus revenue estimate of $178.96 million.

3 brokerages have issued 12 month target prices for Cutera's shares. Their forecasts range from $45.00 to $45.00. On average, they anticipate Cutera's stock price to reach $45.00 in the next year. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Price Targets for Cutera.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cutera.

Media stories about CUTR stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Cutera earned a news sentiment score of -2.5 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Cutera.

Some companies that are related to Cutera include InMode (INMD), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Zynex (ZYXI), Stereotaxis (STXS), Semler Scientific (SMLR), BioLife Solutions (BLFS), Viewray (VRAY), Rockwell Medical (RMTI), Fonar (FONR), Soleno Therapeutics (SLNO), Edap Tms (EDAP), BioSig Technologies (BSGM) and Second Sight Medical Products (EYES).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), Roku (ROKU), Pfizer (PFE), Biogen (BIIB), Celgene (CELG), Clovis Oncology (CLVS), Corcept Therapeutics (CORT) and Costco Wholesale (COST).

Cutera's stock is owned by many different of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (1.05%) and Wedge Capital Management L L P NC (0.18%). Company insiders that own Cutera stock include David A Gollnick, Gregory A Barrett, J Daniel Plants, James A Reinstein and Larry Laber. View Institutional Ownership Trends for Cutera.

CUTR stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC. View Insider Buying and Selling for Cutera.

CUTR stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett, J Daniel Plants and James A Reinstein. View Insider Buying and Selling for Cutera.

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CUTR stock can currently be purchased for approximately $33.91.

Cutera has a market capitalization of $482.54 million and generates $162.72 million in revenue each year. The medical device company earns $-30,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. Cutera employs 402 workers across the globe.View Additional Information About Cutera.

The official website for Cutera is http://www.cutera.com/.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]